Perrigo (PRGO) Curent Deferred Tax Liability (2013 - 2015)
Perrigo's (PRGO) quarterly Curent Deferred Tax Liability came in at $104.5 million in Q3 2015, up 2330.23% year-on-year from $4.3 million in Q3 2014, and up 31.12% on a QoQ basis from $79.7 million in Q2 2015.
Perrigo (PRGO) Curent Deferred Tax Liability (2013 - 2015) Analysis & Trends
Perrigo (PRGO) has 3 years of Curent Deferred Tax Liability data on file, last reported at $104.5 million in Q3 2015.
- On a quarterly basis, Curent Deferred Tax Liability rose 2330.23% year-over-year to $104.5 million in Q3 2015; TTM through Sep 2015 was $104.5 million, a 2330.23% increase from a year earlier, with the FY2015 full-year figure at $79.7 million, up 7145.45% from the prior year.
- Curent Deferred Tax Liability for Q3 2015 stood at $104.5 million, up from $79.7 million in the prior quarter.
- Over the last five years, Curent Deferred Tax Liability for PRGO reached as high as $104.5 million in Q3 2015 and fell as low as $100000.0 in Q1 2014.
- Historically, Curent Deferred Tax Liability has averaged $27.8 million across 3 years, with a median of $4.3 million in 2014.
- Across the five-year window, Curent Deferred Tax Liability soared 450.0% in 2014 and jumped 7145.45% in 2015, its largest moves.
- Year by year, Curent Deferred Tax Liability stood at $200000.0 in 2013, then surged by 2150.0% to $4.5 million in 2014, then soared by 2222.22% to $104.5 million in 2015.
- Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $104.5 million in Q3 2015, $79.7 million in Q2 2015, and $4.5 million in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 26, 2015 | 104.50 Mn |
| Sep 26, 2015 | 104.50 Mn |
| Jun 27, 2015 | 79.70 Mn |
| Jun 27, 2015 | 79.70 Mn |
| Dec 27, 2014 | 4.50 Mn |
| Dec 27, 2014 | 4.50 Mn |
| Sep 27, 2014 | 4.30 Mn |
| Sep 27, 2014 | 4.30 Mn |
| Jun 28, 2014 | 1.10 Mn |
| Jun 28, 2014 | 1.10 Mn |
| Mar 29, 2014 | 100,000.00 |
| Mar 29, 2014 | 100,000.00 |
| Jun 29, 2013 | 200,000.00 |
| Jun 29, 2013 | 200,000.00 |